36311 |
Oncology |
Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes ... |
CANCERS 2020 10.3390/cancers12040943 |
이지연 |
2020 |
36310 |
Pathology |
TPK1 as a predictive marker for the anti-tumour effects of simvastatin... |
PATHOL RES PRACT 2020 10.1016/j.prp.2020.152820 |
이지연 |
2020 |
36309 |
Pathology |
High PD-L1 expression in gastric cancer (GC) patients and correlation ... |
PATHOL RES PRACT 2020 10.1016/j.prp.2020.152881 |
이지연 |
2020 |
36308 |
Pathology |
High-level FGFR2 amplification is associated with poor prognosis and L... |
PATHOL RES PRACT 2020 10.1016/j.prp.2020.152878 |
이지연 |
2020 |
36307 |
Oncology |
First-in-human phase I trial of anti-hepatocyte growth factor antibody... |
THER ADV MED ONCOL 2020 10.1177/1758835920926796 |
이지연 |
2020 |
36306 |
Oncology |
Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gas... |
J ONCOL 2020 10.1155/2020/4659062 |
이지연 |
2020 |
36305 |
Pathology |
Correlation between RICTOR overexpression and amplification in advance... |
PATHOL RES PRACT 2020 10.1016/j.prp.2019.152734 |
이지연 |
2020 |
36304 |
Oncology |
Clinical scoring system for the prediction of survival of patients wit... |
ESMO OPEN 2020 10.1136/esmoopen-2020-000670 |
이지연 |
2020 |
36303 |
Oncology |
Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-La... |
TARGET ONCOL 2020 10.1007/s11523-020-00706-0 |
이지연 |
2020 |
36302 |
Oncology |
Tumor Mutational Burden Determined by Panel Sequencing Predicts Surviv... |
Front Oncol 2020 10.3389/fonc.2020.00314 |
이지연 |
2020 |